These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 10485834)

  • 1. Commentary: contribution of pathology to drug research and development in the next decade.
    Harleman JH
    Toxicol Pathol; 1999; 27(4):479-80. PubMed ID: 10485834
    [No Abstract]   [Full Text] [Related]  

  • 2. Looking forward in pharmaceutical process chemistry.
    Davies IW; Welch CJ
    Science; 2009 Aug; 325(5941):701-4. PubMed ID: 19661417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frontiers in GPCR research.
    Stark H
    Arch Pharm (Weinheim); 2005 Jun; 338(5-6):207. PubMed ID: 15962349
    [No Abstract]   [Full Text] [Related]  

  • 4. Perspective from the founding editors. Preface.
    Juliano R; Poste G; Tomlinson E
    Adv Drug Deliv Rev; 2013 Jan; 65(1):3-4. PubMed ID: 22940253
    [No Abstract]   [Full Text] [Related]  

  • 5. At the flick of a switch: epigenetic drugs.
    Pray L
    Chem Biol; 2008 Jul; 15(7):640-1. PubMed ID: 18634998
    [No Abstract]   [Full Text] [Related]  

  • 6. Anticancer drug discovery and development.
    Colotta F
    Adv Exp Med Biol; 2008; 610():19-42. PubMed ID: 18593013
    [No Abstract]   [Full Text] [Related]  

  • 7. Label-free technologies and pharmacology.
    Fang Y
    Pharmacol Res; 2016 Jun; 108():88-89. PubMed ID: 27155057
    [No Abstract]   [Full Text] [Related]  

  • 8. Top of the form.
    Brown M
    Drug Discov Today; 2002 Oct; 7(20):1026-7. PubMed ID: 12546885
    [No Abstract]   [Full Text] [Related]  

  • 9. Noordwijkerhout-Camerino--15th Symposium. Trends in drug research.
    Triggle DJ
    IDrugs; 2005 Jul; 8(7):563-6. PubMed ID: 15973564
    [No Abstract]   [Full Text] [Related]  

  • 10. Use of high-content analysis for compound screening and target selection.
    Rausch O
    IDrugs; 2005 Jul; 8(7):573-7. PubMed ID: 15973566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natural products in drug discovery: present status and perspectives.
    Molinari G
    Adv Exp Med Biol; 2009; 655():13-27. PubMed ID: 20047031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ligand-based vascular targeting of disease.
    Rybak JN; Trachsel E; Scheuermann J; Neri D
    ChemMedChem; 2007 Jan; 2(1):22-40. PubMed ID: 17154429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tigecycline.
    Wenzel R; Bate G; Kirkpatrick P
    Nat Rev Drug Discov; 2005 Oct; 4(10):809-10. PubMed ID: 16237846
    [No Abstract]   [Full Text] [Related]  

  • 14. Timely synthetic support for medicinal chemists.
    Potoski J
    Drug Discov Today; 2005 Jan; 10(2):115-20. PubMed ID: 15718160
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Can biotech deliver new antibiotics?
    Barrett JF
    Curr Opin Microbiol; 2005 Oct; 8(5):498-503. PubMed ID: 16125445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microfluidic technologies in drug discovery.
    Pihl J; Karlsson M; Chiu DT
    Drug Discov Today; 2005 Oct; 10(20):1377-83. PubMed ID: 16253876
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Value of pharmaceutical sciences.
    Borchardt RT
    Pharm Res; 1997 Aug; 14(8):958-66. PubMed ID: 9279873
    [No Abstract]   [Full Text] [Related]  

  • 18. Nanocarriers.
    Torchilin VP
    Pharm Res; 2007 Dec; 24(12):2333-4. PubMed ID: 17934800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rho Chi lecture. Pharmaceutical sciences in the next millennium.
    Triggle DJ
    Ann Pharmacother; 1999 Feb; 33(2):241-6. PubMed ID: 10084422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemical modification of gene silencing oligonucleotides for drug discovery and development.
    Chen X; Dudgeon N; Shen L; Wang JH
    Drug Discov Today; 2005 Apr; 10(8):587-93. PubMed ID: 15837602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.